Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California. more
Time Frame | FLGT | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.54% | -2.27% | -0.57% |
1-Month Return | 6.3% | -3.96% | 1.21% |
3-Month Return | -12.39% | -9.7% | 7.57% |
6-Month Return | 0.98% | -3.37% | 11.45% |
1-Year Return | -31.51% | 3.71% | 28.48% |
3-Year Return | -77.48% | 3.8% | 29.52% |
5-Year Return | 44.29% | 39.78% | 90.66% |
10-Year Return | 113.29% | 106.91% | 203.75% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 32.53M | 421.71M | 992.58M | 618.97M | 289.21M | [{"date":"2019-12-31","value":3.28,"profit":true},{"date":"2020-12-31","value":42.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":62.36,"profit":true},{"date":"2023-12-31","value":29.14,"profit":true}] |
Cost of Revenue | 14.11M | 89.81M | 215.53M | 252.07M | 184.76M | [{"date":"2019-12-31","value":5.6,"profit":true},{"date":"2020-12-31","value":35.63,"profit":true},{"date":"2021-12-31","value":85.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.3,"profit":true}] |
Gross Profit | 18.42M | 331.90M | 777.05M | 366.90M | 104.46M | [{"date":"2019-12-31","value":2.37,"profit":true},{"date":"2020-12-31","value":42.71,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":47.22,"profit":true},{"date":"2023-12-31","value":13.44,"profit":true}] |
Gross Margin | 56.63% | 78.70% | 78.29% | 59.28% | 36.12% | [{"date":"2019-12-31","value":71.95,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.47,"profit":true},{"date":"2022-12-31","value":75.32,"profit":true},{"date":"2023-12-31","value":45.89,"profit":true}] |
Operating Expenses | 18.85M | 41.75M | 104.34M | 185.40M | 171.91M | [{"date":"2019-12-31","value":10.17,"profit":true},{"date":"2020-12-31","value":22.52,"profit":true},{"date":"2021-12-31","value":56.28,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.72,"profit":true}] |
Operating Income | (428.00K) | 290.16M | 104.34M | 178.53M | (72.69M) | [{"date":"2019-12-31","value":-0.15,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.96,"profit":true},{"date":"2022-12-31","value":61.53,"profit":true},{"date":"2023-12-31","value":-25.05,"profit":false}] |
Total Non-Operating Income/Expense | 1.67M | 3.05M | 2.69M | 11.00M | (82.78M) | [{"date":"2019-12-31","value":15.22,"profit":true},{"date":"2020-12-31","value":27.76,"profit":true},{"date":"2021-12-31","value":24.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-752.83,"profit":false}] |
Pre-Tax Income | 409.00K | 291.68M | 104.34M | 184.03M | (174.09M) | [{"date":"2019-12-31","value":0.14,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":35.77,"profit":true},{"date":"2022-12-31","value":63.09,"profit":true},{"date":"2023-12-31","value":-59.68,"profit":false}] |
Income Taxes | 43.00K | 72.53M | 174.79M | 42.10M | 1.15M | [{"date":"2019-12-31","value":0.02,"profit":true},{"date":"2020-12-31","value":41.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.09,"profit":true},{"date":"2023-12-31","value":0.66,"profit":true}] |
Income After Taxes | 366.00K | 219.15M | (70.46M) | 141.92M | (175.24M) | [{"date":"2019-12-31","value":0.17,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-32.15,"profit":false},{"date":"2022-12-31","value":64.76,"profit":true},{"date":"2023-12-31","value":-79.96,"profit":false}] |
Income From Continuous Operations | (411.00K) | 219.15M | 506.24M | 141.92M | (64.98M) | [{"date":"2019-12-31","value":-0.08,"profit":false},{"date":"2020-12-31","value":43.29,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":28.03,"profit":true},{"date":"2023-12-31","value":-12.84,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 366.00K | 214.31M | 104.34M | 143.40M | (167.82M) | [{"date":"2019-12-31","value":0.17,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":48.69,"profit":true},{"date":"2022-12-31","value":66.91,"profit":true},{"date":"2023-12-31","value":-78.31,"profit":false}] |
EPS (Diluted) | 0.18 | 8.42 | 16.35 | 5.70 | (0.41) | [{"date":"2019-12-31","value":1.1,"profit":true},{"date":"2020-12-31","value":51.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.86,"profit":true},{"date":"2023-12-31","value":-2.51,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
FLGT | |
---|---|
Cash Ratio | 2.88 |
Current Ratio | 4.41 |
Quick Ratio | 4.30 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
FLGT | |
---|---|
ROA (LTM) | -4.15% |
ROE (LTM) | -14.35% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
FLGT | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.08 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.92 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
FLGT | |
---|---|
Trailing PE | NM |
Forward PE | 7.94 |
P/S (TTM) | 2.23 |
P/B | 0.54 |
Price/FCF | NM |
EV/R | 1.49 |
EV/Ebitda | NM |
PEG | 1.32 |
Fulgent Genetics Inc (FLGT) share price today is $19.58
Yes, Indians can buy shares of Fulgent Genetics Inc (FLGT) on Vested. To buy Fulgent Genetics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in FLGT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Fulgent Genetics Inc (FLGT) via the Vested app. You can start investing in Fulgent Genetics Inc (FLGT) with a minimum investment of $1.
You can invest in shares of Fulgent Genetics Inc (FLGT) via Vested in three simple steps:
The 52-week high price of Fulgent Genetics Inc (FLGT) is $30.68. The 52-week low price of Fulgent Genetics Inc (FLGT) is $16.56.
The price-to-earnings (P/E) ratio of Fulgent Genetics Inc (FLGT) is
The price-to-book (P/B) ratio of Fulgent Genetics Inc (FLGT) is 0.54
The dividend yield of Fulgent Genetics Inc (FLGT) is 0.00%
The market capitalization of Fulgent Genetics Inc (FLGT) is $619.08M
The stock symbol (or ticker) of Fulgent Genetics Inc is FLGT